PD-1 Inhibitors Combined with Antiangiogenic Therapy with or Without Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Propensity Matching Analysis

BACKGROUND: At present, it is not known whether targeting plus immunotherapy combined with transarterial chemoembolization (TACE) can improve the efficacy of hepatocellular carcinoma (HCC). The aim of this retrospective experiment was to explore the difference in clinical efficacy between antiangiog...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Han, Su, Ke, Guo, Lu, Jiang, Yi, Xu, Ke, Gu, Tao, Chen, Jiali, Wu, Zhenying, Wang, Pan, Zhang, Xi, Yan, Yushan, Li, Siyuan, Wu, Xue, Han, Lei, He, Kun, Wen, Lianbin, Li, Bo, Han, Yunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395511/
https://www.ncbi.nlm.nih.gov/pubmed/37538403
http://dx.doi.org/10.2147/JHC.S415843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395511/
https://www.ncbi.nlm.nih.gov/pubmed/37538403
http://dx.doi.org/10.2147/JHC.S415843

Ejemplares similares